Pay in 4 interest-free payments of $6.04 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Receptor binding and signaling assays demonstrate that AOD 9604 does not activate the growth hormone receptor, distinguishing it from full-length GH
carnitine supports fatty-acid transport
The peptide is primarily studied for targeted lipolysis the breakdown of stored triglycerides as well as adipose tissue metabolism, body composition endpoints, and more recently chondrocyte and cartilage repair models
Prescribing decisions should involve a physician experienced in peptide therapy, baseline lab work (fasting glucose, insulin, IGF-1, CBC, CMP), and scheduled follow-up labs at 6 to 8 weeks
US$ 22.42
US$ 21.16
US$ 24.50
